• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Small PACS firms find survival difficult

Article

Small PACS firms find survival difficultShakeout continues at a furious pace in the PACS and teleradiology markets, with Access Radiology and EMED apparently the latest firms to tie their futures together. As more of these small companies join

Small PACS firms find survival difficult

Shakeout continues at a furious pace in the PACS and teleradiology markets, with Access Radiology and EMED apparently the latest firms to tie their futures together. As more of these small companies join forces or are bought out by larger companies, power in the PACS industry is becoming concentrated in fewer and fewer hands.

While mergers and acquisitions provide a new lease on life for small companies and fill out product lines for larger firms, they also accentuate the tenuous existence of small firms and their difficulty in attracting customers.

Despite the hardships of the marketplace, smaller PACS firms have pioneered much of the leading-edge technology that is now standard issue for PACS companies. For example, the use of Windows NT and Web protocols, now employed by nearly all leading PACS firms, were trends begun by smaller firms.

Interest is growing in one-stop shopping for PACS and healthcare information systems, however, and there's no question that consolidation will continue in this sector. Smaller firms, particularly those selling directly to end users, will likely continue to struggle, with few exceptions.

All is not lost for small vendors, however. Innovative companies will continue to come into the market and generate useful PACS technology-but that technology will probably find its way to customers through OEM relationships rather than direct sales initiated by its developer. In the PACS market of the future, David and Goliath will find success through cooperation rather than confrontation.

-Erik L. Ridley, Editor

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.